The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Hemostatic Agents-Global Market Insights and Sales Trends 2025
Synopsis
Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
The global Hemostatic Agents market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Hemostatic Agents in various end use industries. The expanding demands from the Hospitals, Surgical Centers and Nursing Homes,, are propelling Hemostatic Agents market. Gelation Sponge, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oxidized Regenerated Cellulose Based Hemostats segment is estimated at % CAGR for the next seven-year period.
The world's leading manufacturers of hemostatics are Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LiLifeSciences, B Braun Melsungen and Gelita Medical.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hemostatic Agents, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hemostatic Agents market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hemostatic Agents market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hemostatic Agents sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hemostatic Agents covered in this report include Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences and B Braun Melsungen, etc.
The global Hemostatic Agents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica
CryoLife
BioCer Entwicklungs
Biom’Up SAS
Global Hemostatic Agents market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hemostatic Agents market, Segment by Type:
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Global Hemostatic Agents market, by Application
Hospitals
Surgical Centers
Nursing Homes
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hemostatic Agents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hemostatic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
The global Hemostatic Agents market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Hemostatic Agents in various end use industries. The expanding demands from the Hospitals, Surgical Centers and Nursing Homes,, are propelling Hemostatic Agents market. Gelation Sponge, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oxidized Regenerated Cellulose Based Hemostats segment is estimated at % CAGR for the next seven-year period.
The world's leading manufacturers of hemostatics are Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LiLifeSciences, B Braun Melsungen and Gelita Medical.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hemostatic Agents, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hemostatic Agents market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hemostatic Agents market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hemostatic Agents sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hemostatic Agents covered in this report include Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences and B Braun Melsungen, etc.
The global Hemostatic Agents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica
CryoLife
BioCer Entwicklungs
Biom’Up SAS
Global Hemostatic Agents market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hemostatic Agents market, Segment by Type:
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Global Hemostatic Agents market, by Application
Hospitals
Surgical Centers
Nursing Homes
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hemostatic Agents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hemostatic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Hemostatic Agents Market Overview
1.1 Hemostatic Agents Product Overview
1.2 Hemostatic Agents Market Segment by Type
1.2.1 Gelation Sponge
1.2.2 Oxidized Regenerated Cellulose Based Hemostats
1.2.3 Others
1.3 Global Hemostatic Agents Market Size by Type
1.3.1 Global Hemostatic Agents Market Size Overview by Type (2018-2029)
1.3.2 Global Hemostatic Agents Historic Market Size Review by Type (2018-2023)
1.3.3 Global Hemostatic Agents Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hemostatic Agents Sales Breakdown by Type (2018-2023)
1.4.2 Europe Hemostatic Agents Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Hemostatic Agents Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Hemostatic Agents Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Hemostatic Agents Sales Breakdown by Type (2018-2023)
2 Global Hemostatic Agents Market Competition by Company
2.1 Global Top Players by Hemostatic Agents Sales (2018-2023)
2.2 Global Top Players by Hemostatic Agents Revenue (2018-2023)
2.3 Global Top Players by Hemostatic Agents Price (2018-2023)
2.4 Global Top Manufacturers Hemostatic Agents Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hemostatic Agents Market Competitive Situation and Trends
2.5.1 Hemostatic Agents Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Hemostatic Agents Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hemostatic Agents as of 2022)
2.7 Date of Key Manufacturers Enter into Hemostatic Agents Market
2.8 Key Manufacturers Hemostatic Agents Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hemostatic Agents Status and Outlook by Region
3.1 Global Hemostatic Agents Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Hemostatic Agents Historic Market Size by Region
3.2.1 Global Hemostatic Agents Sales in Volume by Region (2018-2023)
3.2.2 Global Hemostatic Agents Sales in Value by Region (2018-2023)
3.2.3 Global Hemostatic Agents Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Hemostatic Agents Forecasted Market Size by Region
3.3.1 Global Hemostatic Agents Sales in Volume by Region (2024-2029)
3.3.2 Global Hemostatic Agents Sales in Value by Region (2024-2029)
3.3.3 Global Hemostatic Agents Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Hemostatic Agents by Application
4.1 Hemostatic Agents Market Segment by Application
4.1.1 Hospitals
4.1.2 Surgical Centers
4.1.3 Nursing Homes
4.2 Global Hemostatic Agents Market Size by Application
4.2.1 Global Hemostatic Agents Market Size Overview by Application (2018-2029)
4.2.2 Global Hemostatic Agents Historic Market Size Review by Application (2018-2023)
4.2.3 Global Hemostatic Agents Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hemostatic Agents Sales Breakdown by Application (2018-2023)
4.3.2 Europe Hemostatic Agents Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Hemostatic Agents Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Hemostatic Agents Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Hemostatic Agents Sales Breakdown by Application (2018-2023)
5 North America Hemostatic Agents by Country
5.1 North America Hemostatic Agents Historic Market Size by Country
5.1.1 North America Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Hemostatic Agents Sales in Volume by Country (2018-2023)
5.1.3 North America Hemostatic Agents Sales in Value by Country (2018-2023)
5.2 North America Hemostatic Agents Forecasted Market Size by Country
5.2.1 North America Hemostatic Agents Sales in Volume by Country (2024-2029)
5.2.2 North America Hemostatic Agents Sales in Value by Country (2024-2029)
6 Europe Hemostatic Agents by Country
6.1 Europe Hemostatic Agents Historic Market Size by Country
6.1.1 Europe Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Hemostatic Agents Sales in Volume by Country (2018-2023)
6.1.3 Europe Hemostatic Agents Sales in Value by Country (2018-2023)
6.2 Europe Hemostatic Agents Forecasted Market Size by Country
6.2.1 Europe Hemostatic Agents Sales in Volume by Country (2024-2029)
6.2.2 Europe Hemostatic Agents Sales in Value by Country (2024-2029)
7 Asia-Pacific Hemostatic Agents by Region
7.1 Asia-Pacific Hemostatic Agents Historic Market Size by Region
7.1.1 Asia-Pacific Hemostatic Agents Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Hemostatic Agents Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Hemostatic Agents Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Hemostatic Agents Forecasted Market Size by Region
7.2.1 Asia-Pacific Hemostatic Agents Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Hemostatic Agents Sales in Value by Region (2024-2029)
8 Latin America Hemostatic Agents by Country
8.1 Latin America Hemostatic Agents Historic Market Size by Country
8.1.1 Latin America Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Hemostatic Agents Sales in Volume by Country (2018-2023)
8.1.3 Latin America Hemostatic Agents Sales in Value by Country (2018-2023)
8.2 Latin America Hemostatic Agents Forecasted Market Size by Country
8.2.1 Latin America Hemostatic Agents Sales in Volume by Country (2024-2029)
8.2.2 Latin America Hemostatic Agents Sales in Value by Country (2024-2029)
9 Middle East and Africa Hemostatic Agents by Country
9.1 Middle East and Africa Hemostatic Agents Historic Market Size by Country
9.1.1 Middle East and Africa Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Hemostatic Agents Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Hemostatic Agents Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Hemostatic Agents Forecasted Market Size by Country
9.2.1 Middle East and Africa Hemostatic Agents Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Hemostatic Agents Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Ethicon
10.1.1 Ethicon Company Information
10.1.2 Ethicon Introduction and Business Overview
10.1.3 Ethicon Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Ethicon Hemostatic Agents Products Offered
10.1.5 Ethicon Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Pfizer Hemostatic Agents Products Offered
10.2.5 Pfizer Recent Development
10.3 Baxter International
10.3.1 Baxter International Company Information
10.3.2 Baxter International Introduction and Business Overview
10.3.3 Baxter International Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Baxter International Hemostatic Agents Products Offered
10.3.5 Baxter International Recent Development
10.4 C. R. Bard
10.4.1 C. R. Bard Company Information
10.4.2 C. R. Bard Introduction and Business Overview
10.4.3 C. R. Bard Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.4.4 C. R. Bard Hemostatic Agents Products Offered
10.4.5 C. R. Bard Recent Development
10.5 The Medicines Company
10.5.1 The Medicines Company Company Information
10.5.2 The Medicines Company Introduction and Business Overview
10.5.3 The Medicines Company Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.5.4 The Medicines Company Hemostatic Agents Products Offered
10.5.5 The Medicines Company Recent Development
10.6 Anika Therapeutics
10.6.1 Anika Therapeutics Company Information
10.6.2 Anika Therapeutics Introduction and Business Overview
10.6.3 Anika Therapeutics Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Anika Therapeutics Hemostatic Agents Products Offered
10.6.5 Anika Therapeutics Recent Development
10.7 Advanced Medical Solutions
10.7.1 Advanced Medical Solutions Company Information
10.7.2 Advanced Medical Solutions Introduction and Business Overview
10.7.3 Advanced Medical Solutions Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Advanced Medical Solutions Hemostatic Agents Products Offered
10.7.5 Advanced Medical Solutions Recent Development
10.8 Integra LifeSciences
10.8.1 Integra LifeSciences Company Information
10.8.2 Integra LifeSciences Introduction and Business Overview
10.8.3 Integra LifeSciences Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Integra LifeSciences Hemostatic Agents Products Offered
10.8.5 Integra LifeSciences Recent Development
10.9 B Braun Melsungen
10.9.1 B Braun Melsungen Company Information
10.9.2 B Braun Melsungen Introduction and Business Overview
10.9.3 B Braun Melsungen Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.9.4 B Braun Melsungen Hemostatic Agents Products Offered
10.9.5 B Braun Melsungen Recent Development
10.10 Gelita Medical
10.10.1 Gelita Medical Company Information
10.10.2 Gelita Medical Introduction and Business Overview
10.10.3 Gelita Medical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Gelita Medical Hemostatic Agents Products Offered
10.10.5 Gelita Medical Recent Development
10.11 Equimedical
10.11.1 Equimedical Company Information
10.11.2 Equimedical Introduction and Business Overview
10.11.3 Equimedical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Equimedical Hemostatic Agents Products Offered
10.11.5 Equimedical Recent Development
10.12 Vascular Solutions
10.12.1 Vascular Solutions Company Information
10.12.2 Vascular Solutions Introduction and Business Overview
10.12.3 Vascular Solutions Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Vascular Solutions Hemostatic Agents Products Offered
10.12.5 Vascular Solutions Recent Development
10.13 Marine Polymer Technologies
10.13.1 Marine Polymer Technologies Company Information
10.13.2 Marine Polymer Technologies Introduction and Business Overview
10.13.3 Marine Polymer Technologies Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Marine Polymer Technologies Hemostatic Agents Products Offered
10.13.5 Marine Polymer Technologies Recent Development
10.14 Z-Medica
10.14.1 Z-Medica Company Information
10.14.2 Z-Medica Introduction and Business Overview
10.14.3 Z-Medica Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Z-Medica Hemostatic Agents Products Offered
10.14.5 Z-Medica Recent Development
10.15 CryoLife
10.15.1 CryoLife Company Information
10.15.2 CryoLife Introduction and Business Overview
10.15.3 CryoLife Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.15.4 CryoLife Hemostatic Agents Products Offered
10.15.5 CryoLife Recent Development
10.16 BioCer Entwicklungs
10.16.1 BioCer Entwicklungs Company Information
10.16.2 BioCer Entwicklungs Introduction and Business Overview
10.16.3 BioCer Entwicklungs Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.16.4 BioCer Entwicklungs Hemostatic Agents Products Offered
10.16.5 BioCer Entwicklungs Recent Development
10.17 Biom’Up SAS
10.17.1 Biom’Up SAS Company Information
10.17.2 Biom’Up SAS Introduction and Business Overview
10.17.3 Biom’Up SAS Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Biom’Up SAS Hemostatic Agents Products Offered
10.17.5 Biom’Up SAS Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hemostatic Agents Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hemostatic Agents Industrial Chain Analysis
11.4 Hemostatic Agents Market Dynamics
11.4.1 Hemostatic Agents Industry Trends
11.4.2 Hemostatic Agents Market Drivers
11.4.3 Hemostatic Agents Market Challenges
11.4.4 Hemostatic Agents Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hemostatic Agents Distributors
12.3 Hemostatic Agents Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
